Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations: JACC State-of-the-Art Review.
Journal Article (Journal Article;Review)
Fine particulate air pollution <2.5 μm in diameter (PM2.5) is a major environmental threat to global public health. Multiple national and international medical and governmental organizations have recognized PM2.5 as a risk factor for cardiopulmonary diseases. A growing body of evidence indicates that several personal-level approaches that reduce exposures to PM2.5 can lead to improvements in health endpoints. Novel and forward-thinking strategies including randomized clinical trials are important to validate key aspects (e.g., feasibility, efficacy, health benefits, risks, burden, costs) of the various protective interventions, in particular among real-world susceptible and vulnerable populations. This paper summarizes the discussions and conclusions from an expert workshop, Reducing the Cardiopulmonary Impact of Particulate Matter Air Pollution in High Risk Populations, held on May 29 to 30, 2019, and convened by the National Institutes of Health, the U.S. Environmental Protection Agency, and the U.S. Centers for Disease Control and Prevention.
Full Text
Duke Authors
Cited Authors
- Newman, JD; Bhatt, DL; Rajagopalan, S; Balmes, JR; Brauer, M; Breysse, PN; Brown, AGM; Carnethon, MR; Cascio, WE; Collman, GW; Fine, LJ; Hansel, NN; Hernandez, A; Hochman, JS; Jerrett, M; Joubert, BR; Kaufman, JD; Malik, AO; Mensah, GA; Newby, DE; Peel, JL; Siegel, J; Siscovick, D; Thompson, BL; Zhang, J; Brook, RD
Published Date
- December 15, 2020
Published In
Volume / Issue
- 76 / 24
Start / End Page
- 2878 - 2894
PubMed ID
- 33303078
Pubmed Central ID
- PMC8040922
Electronic International Standard Serial Number (EISSN)
- 1558-3597
Digital Object Identifier (DOI)
- 10.1016/j.jacc.2020.10.020
Language
- eng
Conference Location
- United States